卒中转诊取栓患者溶栓后血管再通:发生率、预测因素与预测评分
本研究基于4个取栓中心的登记数据(推导队列N=633),发现转诊取栓患者溶栓后早期再通(ER)率约20%。长血栓、近端闭塞和母舰模式独立预测无再通,据此开发的6分评分对无再通有强区分度(C统计量0.854),并在验证队列(n=353)中重复验证(C统计量0.888)。
要点
- 转诊取栓患者溶栓后早期再通率约20%,支持桥接溶栓的获益。
- 长血栓、近端闭塞和母舰模式是无再通的独立预测因素。
- 两个预测评分对无再通特异性高(最高等级>90%),但对再通预测不可靠。
核心结论
- 溶栓后早期再通率可观,支持桥接人群从溶栓中获益。
- 两个预测评分对无再通具有高特异性,但对再通预测不可靠,对试验设计有启示。
研究设计与样本
- 基于4个取栓能力中心2015至2017年的登记数据,纳入转诊取栓且经MRI或CT imaging后溶栓的患者(原位或滴注-转运)。
- 推导队列N=633,验证队列来自另外4个取栓能力中心n=353。
主要发现
- 推导队列中早期再通发生率约20%。
- 在存在磁敏感血管征的患者(n=498)中,长血栓、近端闭塞和母舰模式独立预测无再通。
- 基于上述变量的6分评分对无再通区分度强(C统计量0.854),验证队列C统计量0.888。
- 基于全样本的第二个评分也显示良好区分度并得到类似验证。
- 两个评分的最高等级预测无再通特异性>90%,低等级不能可靠预测再通。
关键数值与推荐
- 6分评分基于长血栓、近端闭塞和母舰模式三个变量。
- 6分评分对无再通的C统计量为0.854(推导队列)和0.888(验证队列)。
- 最高等级评分预测无再通特异性>90%。
临床怎么用
- 可用于识别无再通高风险患者,辅助取栓转运决策。
- 低评分不能可靠预测再通,不应单独用于省略取栓转运。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose—Whether all acute stroke patients with large vessel occlusion need to undergo intravenous thrombolysis before mechanical thrombectomy (MT) is debated as (1) the incidence of post-thrombolysis early recanalization (ER) is still unclear; (2) thrombolysis may be harmful in patients unlikely to recanalize; and, conversely, (3) transfer for MT may be unnecessary in patients highly likely to recanalize. Here, we determined the incidence and predictors of post-thrombolysis ER in patients referred for MT and derive ER prediction scores for trial design. Methods—Registries from 4 MT-capable centers gathering patients referred for MT and thrombolyzed either on site (mothership) or in a non MT-capable center (drip-and-ship) after magnetic resonance– or computed tomography–based imaging between 2015 and 2017. ER was identified on either first angiographic run or noninvasive imaging. In the magnetic resonance imaging subsample, thrombus length was determined on T2*-based susceptibility vessel sign. Independent predictors of no- ER were identified using multivariable logistic regression models, and scores were developed according to the magnitude of regression coefficients. Similar registries from 4 additional MT-capable centers were used as validation cohort. Results—In the derivation cohort (N=633), ER incidence was ≈20%. In patients with susceptibility vessel sign (n=498), no-ER was independently predicted by long thrombus, proximal occlusion, and mothership paradigm. A 6-point score derived from these variables showed strong discriminative power for no-ER (C statistic, 0.854) and was replicated in the validation cohort (n=353; C statistic, 0.888). A second score derived from the whole sample (including negative T2* or computed tomography–based imaging) also showed good discriminative power and was similarly validated. Highest grades on both scores predicted no-ER with >90% specificity, whereas low grades did not reliably predict ER. Conclusions—The substantial ER rate underlines the benefits derived from thrombolysis in bridging populations. Both prediction scores afforded high specificity for no-ER, but not for ER, which has implications for trial design.
引用
- Seners P, Turc G, Naggara O, et al. Post-Thrombolysis Recanalization in Stroke Referrals for Thrombectomy: Incidence, Predictors, and Prediction Scores. Stroke. 2018. PMID: 30730694. doi:10.1161/STROKEAHA.118.022335
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。